Truist Securities Reiterates Buy Rating on Evolent Health (EVH)

Piper Sandler Reiterates Overweight Rating on Evolent Health (EVH)

August 22, 2024 3:59 PM EDT

Piper Sandler analyst Jessica Tassan reiterated an Overweight rating and $38.00 price target on Evolent Health (NYSE: EVH).

The analyst comments "Reuters reports that EVH is weighing sale, following takeover interest. The publication states that EVH has received initial offers and that potential acquirers could include PE firms or ELV (not covered) in combination with a PE partner. Our thoughts on today's news. 1. EVH is defining and dominating the market for value-based specialty care management. This is a $732B TAM which we define our white paper on the space here. 2. EVH has assembled best-in-class... More

BTIG Reiterates Buy Rating on Evolent Health (EVH)

August 22, 2024 3:57 PM EDT

BTIG analyst David Larsen reiterated a Buy rating and $45.00 price target on Evolent Health (NYSE: EVH)

The analyst comments "Shares of EVH are trading up due to an article in Reuters, stating that several private equity firms, and at least one large health plan, are in discussions to potentially acquire EVH. The press report highlights that a process started after EVH received in-bound... More

RBC Capital Reiterates Outperform Rating on Evolent Health (EVH), discusses M&A chatter

August 22, 2024 3:39 PM EDT

RBC Capital analyst Sean Dodge reiterated an Outperform rating and $42.00 price target on Evolent Health (NYSE: EVH).

The analyst said: "There has been a lot of M&A/consolidation over the last 24-months in the value-based care (VBC) space and in our opinion EVH is the best (and most attractively-valued) of the... More

Exclusive-Evolent Health in sale talks after receiving takeover interest, sources say

August 22, 2024 2:44 PM EDT

By Milana Vinn and Anirban Sen

NEW YORK (Reuters) -Evolent Health is in talks with private equity firms and healthcare services providers for a potential sale, in a process that kicked off after it received takeover interest, people familiar with the matter said on Thursday.

Private equity firms TPG, CD&R and KKR are among the parties that have expressed interest in a deal for healthcare software provider Evolent, which has a market value of about $3.8 billion, the sources said. TPG was one of the early investors in Evolent.

Health insurer Elevance Health is also... More

Evolent Health in talks on sale after attracting interest: Reuters

August 22, 2024 2:43 PM EDT

Investing.com -- Evolent Health, a healthcare services provider with a market value of $3.3 billion, is in talks with private equity firms and other companies for a potential sale, Reuters reported Thursday, citing people familiar with the matter.

Private equity firms TPG, CD&R and KKR are among... More

Evolent Health (EVH) October 27.50 and 32.50 calls active after Reuters says in sale talks

August 22, 2024 2:12 PM EDT

Evolent Health (NYSE: EVH) 30-day option implied volatility is at 48; compared to its 52-week range of 30 to 103 after Reuters says in sale talks. Call put ratio 2.4 calls to 1 put with focus on October 27.50 and 32.50 calls.

... More

Evolent Health (EVH) In Sale Talks After Inbound Interest - Reuters

August 22, 2024 1:21 PM EDT

Evolent Health In Sale Talks After Inbound Interest- Reuters

... More